CELLECT Laboratories

CELLECT offers a non-invasive screening method for HPV and cervical cancer using a menstrual blood sample collected via tampon or pad. Their technology extracts and stabilizes DNA for compatibility with existing diagnostic tests, providing a more comfortable, accessible, and cost-effective alternative to traditional Pap smears.

Traction –/10

HQ unknown

3300+ followers

Biotechnology
Healthcare Technology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

2 founders

CT Murphy

Applying Nano Solutions to Women’s Biggest Problems

Ibukun Elebute

Co-Founder/COO

Product

Features

CELLECT offers a non-invasive screening method for HPV and cervical cancer using a menstrual blood sample collected via tampon or pad. Their technology extracts and stabilizes DNA for compatibility with existing diagnostic tests, providing a more comfortable, accessible, and cost-effective alternative to traditional Pap smears.